Position in NVS
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$44,038
+$1,116 QoQ
Shares Held
281
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,440
of 1,603 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ALBION FINANCIAL GROUP /UT holds $22,152,027 across 13 Drug Manufacturers - General names. NVS ranks #9 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
24,267 | $8,787,566 | |
| 2 | ABBV |
AbbVie Inc.
|
18,850 | $4,743,414 | |
| 3 | MRK |
Merck & Co., Inc.
|
30,544 | $3,924,904 | |
| 4 | JNJ |
Johnson & Johnson
|
11,083 | $2,814,749 | |
| 5 | LLY |
ELI LILLY & Co
|
1,246 | $1,494,489 | |
| 6 | PFE |
Pfizer Inc
|
7,059 | $169,980 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
577 | $72,898 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
800 | $46,096 |
All Filings in NVS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,038 | 281 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $42,922 | 281 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $38,741 | 281 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $36,035 | 281 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $30,373 | 251 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $27,981 | 251 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $24,424 | 251 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $10,466 | 91 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $9,687 | 91 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $8,802 | 91 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $9,188 | 91 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $9,269 | 91 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $9,182 | 91 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $8,372 | 91 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $8,255 | 91 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $6,916 | 91 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $7,692 | 91 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $15,882 | 181 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $7,959 | 91 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $7,441 | 91 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $13,138 | 144 | Shares | Sole | 2021-08-12 | |
| 2020-12-31 | $8,593 | 91 | Shares | Sole | 2021-02-19 | |
| No filing history on record for this holder in this stock. | ||||||